Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
HALOZYME THERAPEUTICS, INC. (HALO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS"
05/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS"
05/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/13/2023 8-K Other Events  Interactive Data
02/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/06/2023 8-K Quarterly results
01/10/2023 8-K Quarterly results
11/08/2022 8-K Quarterly results
08/19/2022 8-K Quarterly results
08/18/2022 8-K Quarterly results
08/16/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/09/2022 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Independent Registered Public Accounting Firm",
"NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION"
08/09/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "HALOZYME REPORTS SECOND QUARTER 2022 FINANCIAL AND OPERATING RESULTS"
05/24/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/06/2022 8-K Quarterly results
04/13/2022 8-K Investor presentation
Docs: "Agreement and Plan of Merger, by and among Halozyme Therapeutics, Inc., Atlas Merger Sub, Inc. and Antares Pharma, Inc",
"Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader",
"Investor Presentation of Halozyme Therapeutics, Inc."
03/21/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
03/15/2022 8-K Appointed a new director
02/22/2022 8-K Quarterly results
Docs: "HALOZYME REPORTS FOURTH QUARTER 2021 AND FULL YEAR RESULTS"
02/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Halozyme Appoints New Chief Financial Officer"
01/10/2022 8-K Investor presentation
Docs: "HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK",
"Halozyme Confidential and Proprietary 40th Annual J.P. Morgan Healthcare Conference Dr. Helen Torley, President and CEO January 10, 2022 Halozyme Confidential and Proprietary 2 Forward-Looking Statements Note: This"
12/29/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "HALOZYME THERAPEUTICS, INC.,",
"SECURITY AGREEMENT"
12/13/2021 8-K Quarterly results
12/10/2021 8-K Quarterly results
11/02/2021 8-K/A Quarterly results
Docs: "HALOZYME REPORTS THIRD QUARTER 2021 RESULTS"
11/02/2021 8-K Quarterly results
Docs: "HALOZYME REPORTS THIRD QUARTER 2021 RESULTS"
08/09/2021 8-K Quarterly results
Docs: "HALOZYME REPORTS SECOND QUARTER 2021 RESULTS"
05/10/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
05/03/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy